P/E ratio for Prestige Consumer Healthcare (PBH)
P/E ratio as of April 2025 (TTM): -52.6
According to Prestige Consumer Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -52.5951. At the end of 2022 the company had a P/E ratio of 14.9.
P/E ratio history for Prestige Consumer Healthcare from 2005 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 14.9 | -7.6% |
| 2021 | 16.1 | 53.12% |
| 2020 | 10.5 | -115.61% |
| 2019 | -67.5 | -368.86% |
| 2018 | 25.1 | 316.07% |
| 2017 | 6.03 | -84.13% |
| 2016 | 38.0 | 53.65% |
| 2015 | 24.8 | -3.05% |
| 2014 | 25.5 | 5.54% |
| 2013 | 24.2 | 9.9% |
| 2012 | 22.0 | 69.92% |
| 2011 | 13.0 | -44.72% |
| 2010 | 23.4 | -1188.1% |
| 2009 | -2.15 | -114.29% |
| 2008 | 15.1 | 30.97% |
| 2007 | 11.5 | -43.43% |
| 2006 | 20.3 | -117.9% |
| 2005 | -114 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 10.8 | -120.57% | 🇬🇧 UK |
 | 13.2 | -125.09% | 🇺🇸 USA |
 | -0.0219 | -99.96% | 🇺🇸 USA |
 | 10.9 | -120.69% | 🇺🇸 USA |
 | 70.4 | -233.93% | 🇮🇱 Israel |
 | 29.3 | -155.72% | 🇨🇭 Switzerland |
 | 26.9 | -151.23% | 🇺🇸 USA |
 | 10.2 | -119.41% | 🇺🇸 USA |
 | 211 | -501.75% | 🇺🇸 USA |
 | 44.3 | -184.24% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.